Results 241 to 250 of about 3,927,548 (340)
Securing the U.S. nucleic acid synthesis industry: a case for safe-harbor information sharing. [PDF]
Seltzer MJ +5 more
europepmc +1 more source
Evaluating the involvement of autolysosomes in the nuclear translocation of fluorescent proteins
Endogenously expressed fluorescent proteins can be degraded by autophagy and transported to cell nuclei via the nuclear pore complex. But in some cell lines, for example, HeLa cells which are positive for immunoreactivity of a receptor ligand, such as UCN I, in cell nuclei, fusion of autolysosome with the nuclear envelope is involved in the nuclear ...
Keiichi Ikeda
wiley +1 more source
Incubator mediated university industry collaboration drives entrepreneurship in Iranian agricultural universities. [PDF]
Jaberi M, Sobhani SMJ, Jamshidi O.
europepmc +1 more source
Le Territoire contesté, l'aménagement du territoire en France, 1934 – 1968
Matthew Wendeln
doaj +1 more source
Skilled labour in the footwear industry of KwaZulu-Natal.
Dashenthren. Moodley
openalex +1 more source
Loss of AMBRA1 activates MAPK and angiogenesis signaling pathways in melanoma cells
Loss of AMBRA1 in melanoma cells activates multiple oncogenic pathways associated with tumor progression. Transcriptomic and protein network analyses revealed that AMBRA1 depletion enhances MAPK/ERK signaling, angiogenesis, TGF‐β/EMT signaling, and Wnt/axon guidance pathways.
Milad Ibrahim +4 more
wiley +1 more source
Reframing Harm and Evidence: Advocacy Coalitions and the Transformation of Finnish Alcohol Policy. [PDF]
Westermarck J +3 more
europepmc +1 more source
IGFBP4 knockdown (KD) impairs preadipocyte proliferation and is associated with IGF1R protein downregulation and attenuated AKT phosphorylation. The mechanisms by which IGFBP4 KD influences the IGF1R/AKT signaling pathway involve newly synthesized proteins and lysosomal degradation pathways. Created in BioRender.
Yujia Guo +6 more
wiley +1 more source
Light people: Radha Nagarajan, Marvell CTO and NAE member. [PDF]
Wan Y, Guo C.
europepmc +1 more source

